A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Generalized Myasthenia Gravis

In brief

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Key facts

Study ID
NCT06456580
Run by
Vor Biopharma
People needed
180
Starts
2024-07-17
Expected to finish
2029-01-01
Last updated by the study team
2026-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.